Start with the basics
At Insulet Corporation, makers of Omnipod®, we were born of innovation and a thirst for finding a better, simpler way. Our goal has been and continues to be to reduce burden and improve outcomes for people with diabetes.
It’s official, the Omnipod® 5 Automated Insulin Delivery (AID) System has been cleared by the Food and Drug Administration (FDA) for individuals ages 6 years and older with type 1 diabetes!
Diabetes wearable devices are tools that give us flexibility at our fingertips when it comes to insulin delivery.
LADA -- latent autoimmune diabetes in adults -- was first acknowledged in
For years, the HbA1c test has been the gold standard of care for assessing a person's blood sugar levels over the previous three months.
Tubed or untethered - most (not all) of us living the subcutaneous insulin delivery life - a.k.a., wearing the Omnipod® System or another insulin pump - are privy to an idiosyncratic phenomenon that happens on occasion with a new infusion site.
I love summer - Warm temps and longer days mean more time outdoors doing some of my absolutely favorite things.
Since the launch of the Omnipod DASH™ System in Spring 2019, we have received many questions from the community regarding coverage. Here are some common questions and answers from our Market Access team.
I’m Dr. Trang Ly - Pediatric Endocrinologist and Medical Director here at Insulet, the makers of the Omnipod® System. I make sure that the products we develop are safe and effective for our users. Here’s a secret – I have the BEST job in the world!
Summertime is here, and with it come more days spent at the pool, beach or enjoying other outdoor activities.
In mid-2015 at the American Association of Diabetes Educators (AADE)’s annual conference, Insulet held the first Sex, Insulin, and Rock ‘N’ Roll live forum. No joke!